6FE6

Solution structure of a last generation P2-P4 macrocyclic inhibitor

SOLUTION NMR

---

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	500 uM [U-99% 15N] HCV NS3 protease, 500 uM NA P2P4M, 100 mM NA sodium chloride, 0.3 % deuterated n-octyl beta-D-glucopyranoside, 1 mM NA DTT, 0.01 % NA sodium azide	95% H2O/5% D2O	100 mM NaCl mM	6.8	1 atm	308	Bruker AVANCE 700
2	2D 1H-15N HSQC	500 uM [U-99% 15N] [U-99% 13C] HCV NS3 protease, 500 uM NA P2P4M, 100 mM NA sodium chloride, 0.3 % deuterated n-octyl beta-D-glucopyranoside, 1 mM NA DTT, 0.01 % NA sodium azide	95% H2O/5% D2O	100 mM NaCl mM	6.8	1 atm	308	Bruker AVANCE 700
3	2D 1H-13C HSQC aliphatic	500 uM [U-99% 15N] [U-99% 13C] HCV NS3 protease, 500 uM NA P2P4M, 100 mM NA sodium chloride, 0.3 % deuterated n-octyl beta-D-glucopyranoside, 1 mM NA DTT, 0.01 % NA sodium azide	100% D2O	100 mM NaCl mM	6.8	1 atm	308	Bruker AVANCE 700
7	2D 1H-13C HSQC aromatic	500 uM [U-99% 15N] [U-99% 13C] HCV NS3 protease, 500 uM NA P2P4M, 100 mM NA sodium chloride, 0.3 % deuterated n-octyl beta-D-glucopyranoside, 1 mM NA DTT, 0.01 % NA sodium azide	100% D2O	100 mM NaCl mM	6.8	1 atm	308	Bruker AVANCE 700
4	3D HNCO	500 uM [U-99% 15N] [U-99% 13C] HCV NS3 protease, 500 uM NA P2P4M, 100 mM NA sodium chloride, 0.3 % deuterated n-octyl beta-D-glucopyranoside, 1 mM NA DTT, 0.01 % NA sodium azide	95% H2O/5% D2O	100 mM NaCl mM	6.8	1 atm	308	Bruker AVANCE 700
5	3D HNCA	500 uM [U-99% 15N] [U-99% 13C] HCV NS3 protease, 500 uM NA P2P4M, 100 mM NA sodium chloride, 0.3 % deuterated n-octyl beta-D-glucopyranoside, 1 mM NA DTT, 0.01 % NA sodium azide	95% H2O/5% D2O	100 mM NaCl mM	6.8	1 atm	308	Bruker AVANCE 700
6	3D HN(CO)CA	500 uM [U-99% 15N] [U-99% 13C] HCV NS3 protease, 500 uM NA P2P4M, 100 mM NA sodium chloride, 0.3 % deuterated n-octyl beta-D-glucopyranoside, 1 mM NA DTT, 0.01 % NA sodium azide	95% H2O/5% D2O	100 mM NaCl mM	6.8	1 atm	308	Bruker AVANCE 700
8	3D CBCANH	500 uM [U-99% 15N] [U-99% 13C] HCV NS3 protease, 500 uM NA P2P4M, 100 mM NA sodium chloride, 0.3 % deuterated n-octyl beta-D-glucopyranoside, 1 mM NA DTT, 0.01 % NA sodium azide	95% H2O/5% D2O	100 mM NaCl mM	6.8	1 atm	308	Bruker AVANCE 700
9	3D CBCA(CO)NH	500 uM [U-99% 15N] [U-99% 13C] HCV NS3 protease, 500 uM NA P2P4M, 100 mM NA sodium chloride, 0.3 % deuterated n-octyl beta-D-glucopyranoside, 1 mM NA DTT, 0.01 % NA sodium azide	95% H2O/5% D2O	100 mM NaCl mM	6.8	1 atm	308	Bruker AVANCE 700
10	3D 1H-15N NOESY	500 uM [U-99% 15N] HCV NS3 protease, 500 uM NA P2P4M, 100 mM NA sodium chloride, 0.3 % deuterated n-octyl beta-D-glucopyranoside, 1 mM NA DTT, 0.01 % NA sodium azide	95% H2O/5% D2O	100 mM NaCl mM	6.8	1 atm	308	Bruker AVANCE 700
12	3D 1H-15N TOCSY	500 uM [U-99% 15N] HCV NS3 protease, 500 uM NA P2P4M, 100 mM NA sodium chloride, 0.3 % deuterated n-octyl beta-D-glucopyranoside, 1 mM NA DTT, 0.01 % NA sodium azide	95% H2O/5% D2O	100 mM NaCl mM	6.8	1 atm	308	Bruker AVANCE 700
11	3D 1H-13C NOESY aliphatic	500 uM [U-99% 15N] [U-99% 13C] HCV NS3 protease, 500 uM NA P2P4M, 100 mM NA sodium chloride, 0.3 % deuterated n-octyl beta-D-glucopyranoside, 1 mM NA DTT, 0.01 % NA sodium azide	95% H2O/5% D2O	100 mM NaCl mM	6.8	1 atm	308	Bruker AVANCE 700
13	3D 1H-13C NOESY aromatic	500 uM [U-99% 15N] [U-99% 13C] HCV NS3 protease, 500 uM NA P2P4M, 100 mM NA sodium chloride, 0.3 % deuterated n-octyl beta-D-glucopyranoside, 1 mM NA DTT, 0.01 % NA sodium azide	95% H2O/5% D2O	100 mM NaCl mM	6.8	1 atm	308	Bruker AVANCE 700
14	F1-edited, F3-filtered 3D HMQC-NOESY	500 uM [U-99% 15N] [U-99% 13C] HCV NS3 protease, 500 uM NA P2P4M, 100 mM NA sodium chloride, 0.3 % deuterated n-octyl beta-D-glucopyranoside, 1 mM NA DTT, 0.01 % NA sodium azide	100% D2O	100 mM NaCl mM	6.8	1 atm	308	Bruker AVANCE 700
15	double-filtered [F1-C/N,F2-C/N]-NOESY	500 uM [U-99% 15N] [U-99% 13C] HCV NS3 protease, 500 uM NA P2P4M, 100 mM NA sodium chloride, 0.3 % deuterated n-octyl beta-D-glucopyranoside, 1 mM NA DTT, 0.01 % NA sodium azide	100% D2O	100 mM NaCl mM	6.8	1 atm	308	Bruker AVANCE 700

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	700

NMR Refinement
Method	Details	Software
molecular dynamics		Xplor-NIH

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	18
Conformers Submitted Total Number	18
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	chemical shift assignment	NMRView		Johnson, One Moon Scientific
5	collection	TopSpin		Bruker Biospin
6	processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
2	structure calculation	Xplor-NIH		Schwieters, Kuszewski, Tjandra and Clore
3	data analysis	TALOS		Cornilescu, Delaglio and Bax
4	peak picking	NMRView		Johnson, One Moon Scientific